127 related articles for article (PubMed ID: 30962170)
1. MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.
Luo C; Pu J; Liu F; Long X; Wang C; Wei H; Tang Q
Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):715-721. PubMed ID: 30962170
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Wang X; Huang Y; Zhuang H; Qian Y; Zhao Q; Yang L; Gu H; Chen J; Guo R; Liu Y
Clin Lab; 2015; 61(9):1331-6. PubMed ID: 26554254
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.
Song J; Zhang N; Cao L; Xiao D; Ye X; Luo E; Zhang Z
Int J Clin Oncol; 2020 Jun; 25(6):1072-1078. PubMed ID: 32162011
[TBL] [Abstract][Full Text] [Related]
4. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.
Li B; Huang P; Qiu J; Liao Y; Hong J; Yuan Y
Med Oncol; 2014 Oct; 31(10):230. PubMed ID: 25218269
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
Su ZX; Zhao J; Rong ZH; Geng WM; Wu YG; Qin CK
Diagn Pathol; 2014 Mar; 9():47. PubMed ID: 24593846
[TBL] [Abstract][Full Text] [Related]
11. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.
Karakatsanis A; Papaconstantinou I; Gazouli M; Lyberopoulou A; Polymeneas G; Voros D
Mol Carcinog; 2013 Apr; 52(4):297-303. PubMed ID: 22213236
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
Gu H; Guo X; Zou L; Zhu H; Zhang J
Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Huang X; Xiong Y; Yang J; Yang G; Li J
Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
[TBL] [Abstract][Full Text] [Related]
15. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
17. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
18. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
19. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Zhang Y; Li Y; Jiang W; Li Q; Lan Y
Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]